Department of Otolaryngology, Washington University School of Medicine, Saint Louis, Missouri, U.S.A.
University of Miami School of Medicine, Miami, Florida, U.S.A.
Laryngoscope. 2020 Jan;130(1):94-100. doi: 10.1002/lary.27856. Epub 2019 Apr 7.
Transoral surgery (TOS) for oropharyngeal carcinoma (OPC) is steadily becoming more routine. Expected posttreatment swallow function is a critical consideration for preoperative counseling. The objective of this study was to identify predictors of swallow dysfunction following TOS for advanced tumor (T)-stage (T3-T4) OPC.
A retrospective review from 1997 to 2016 at a single institution was performed. Eighty-two patients who underwent primary transoral resection of locally advanced OPCs with at least 1 year of postoperative follow-up were included. The primary outcome measure was swallow function, as measured by the Functional Outcomes Swallowing Scale (FOSS) at 1 year postoperatively. Operative reports were reviewed, and the extent of resection and type of reconstruction were documented. Conjunctive consolidation was then performed to incorporate multiple variables and their impact on swallow function into a clinically meaningful classification system.
Fifty-six patients (68%) had acceptable swallowing at 1 year. T4 tumor stage and receipt of adjuvant chemoradiation therapy (CRT) were strongly associated with poor swallowing but did not reach statistical significance. Only base of tongue (BOT) resection ≥50% (odds ratio [OR] 3.19, 95% confidence interval [CI] 1.21-8.43) and older age (OR 1.06, 95% CI 1.00-1.12) were significantly associated. Utilizing T-stage, adjuvant CRT, and BOT resection, a conjunctive consolidation was performed to develop a classification system for swallow dysfunction at 1 year.
This study provides risk stratification for swallow function at 1 year following primary transoral resection of locally advanced OPCs. BOT resection ≥50%, especially when coupled with T4 tumor stage or adjuvant CRT, was associated with poor long-term swallow outcomes.
3 Laryngoscope, 130:94-100, 2020.
经口手术(TOS)治疗口咽癌(OPC)正逐渐成为常规治疗方法。预期的术后吞咽功能是术前咨询的关键考虑因素。本研究的目的是确定 TOS 治疗局部晚期 T 期(T3-T4)OPC 后吞咽功能障碍的预测因素。
对单中心 1997 年至 2016 年的患者进行回顾性研究。纳入 82 例接受 TOS 治疗的局部晚期 OPC 患者,术后至少有 1 年的随访。主要观察指标为术后 1 年的吞咽功能,采用功能结局吞咽量表(FOSS)进行评估。回顾手术报告,记录切除范围和重建类型。然后进行联合一致性分析,将多个变量及其对吞咽功能的影响纳入一个有临床意义的分类系统。
56 例(68%)患者在术后 1 年吞咽功能可接受。T4 肿瘤分期和接受辅助放化疗(CRT)与吞咽功能不良密切相关,但未达到统计学意义。仅舌根切除≥50%(比值比[OR]3.19,95%置信区间[CI]1.21-8.43)和年龄较大(OR 1.06,95%CI 1.00-1.12)与吞咽功能不良显著相关。利用 T 分期、辅助 CRT 和舌根切除,进行联合一致性分析,建立了术后 1 年吞咽功能障碍的分类系统。
本研究为 TOS 治疗局部晚期 OPC 后 1 年的吞咽功能提供了风险分层。舌根切除≥50%,尤其是与 T4 肿瘤分期或辅助 CRT 联合,与长期吞咽功能不良相关。
3 级。喉镜,130:94-100,2020。